StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3089% above fair value
$63.93+2.48 (+4.04%)

Close on Nov 13, 2026Market cap $1.83BP/E 42.1Yield –

Eton Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Eton Pharmaceuticals's profit margin for the twelve months ending Sep 30, 2026 was 35.3%. For fiscal 2025 it was -5.8%, against -9.8% the year before. The highest annual figure on record is -3.0% in fiscal 2023.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-5.8%+4.0
FY2024Dec 31, 2024-9.8%−6.8
FY2023Dec 31, 2023-3.0%+39.5
FY2022Dec 31, 2022-42.4%−33.5
FY2021Dec 31, 2021-9.0%+71709.0
FY2020Dec 31, 2020-71717.9%−69807.6
FY2019Dec 31, 2019-1910.3%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202660.9%+69.4
Q2 FY2026Jun 30, 202630.8%+44.5
Q1 FY2026Mar 31, 20266.4%+15.5
Q4 FY2025Dec 31, 20257.0%+12.1
Q3 FY2025Sep 30, 2025-8.6%−14.7
Q2 FY2025Jun 30, 2025-13.7%+19.9
Q1 FY2025Mar 31, 2025-9.1%+1.1
Q4 FY2024Dec 31, 2024-5.1%+25.7
Q3 FY2024Sep 30, 20246.1%+14.3
Q2 FY2024Jun 30, 2024-33.5%−71.5
Q1 FY2024Mar 31, 2024-10.2%+40.0
Q4 FY2023Dec 31, 2023-30.8%−41.6
Q3 FY2023Sep 30, 2023-8.2%+86.4
Q2 FY2023Jun 30, 202338.0%+59.2
Q1 FY2023Mar 31, 2023-50.2%+194.8
Q4 FY2022Dec 31, 202210.7%−6.3
Q3 FY2022Sep 30, 2022-94.6%+691.7
Q2 FY2022Jun 30, 2022-21.2%+44.6
Q1 FY2022Mar 31, 2022-244.9%−287.9
Q4 FY2021Dec 31, 202117.1%+9507.2
Q3 FY2021Sep 30, 2021-786.3%+22863.7
Q2 FY2021Jun 30, 2021-65.7%+9074.7
Q1 FY2021Mar 31, 202143.0%+630.4
Q4 FY2020Dec 31, 2020-9490.1%−8008.1
Q2 FY2020Jun 30, 2020-23650.0%–
Q1 FY2020Mar 31, 2020-9140.4%–
Q4 FY2019Dec 31, 2019-587.4%–
Q1 FY2019Mar 31, 2019-1482.0%–

More Eton Pharmaceuticals figures

See a number that looks wrong?